Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #Cancer #FDA Approval #Novo Nordisk #Pfizer
Microscopy News Research

Innovative microscopy traces amyloid beta’s underlying structure for neurodegenerative disease research

  • By Journal Updates
  • 21 July 2024
amyloid beta protein structure

Researchers can now discern orientation and other minute characteristics in the nanostructures of biological systems that were previously unseen thanks to a new imaging technology developed by the Lew lab.

Tagged Amyloid Beta Structure, Protein Structure
Research

Discovery of bacteria that can destroy Forever Chemicals

  • By Editor's Desk
  • 20 July 2024
antibiotic resistant bacteria

Per- and polyfluoroalkyl substances, or PFAS, are another name for forever chemicals. These compounds persist in the environment because of their strong carbon-fluorine chemical interactions.

Tagged Bacteria, Forever Chemicals
Biotechnology News Toxicology

CRISPR technology paves the way for a new antidote for Cobra bites

  • By Editor's Desk
  • 19 July 2024
Cobra Snake Image

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Tagged Cobra Venom, CRISPR
Healthcare & Pharmaceuticals News Research

New antibody therapy to neutralize a wide variety of HIV-1 strains

  • By Editor's Desk
  • 19 July 2024
hiv antibody therapy

This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.

Tagged Antibody Therapy, HIV
Gene Therapy News Research

Researchers discovered a new Gene Therapy for muscular dystrophy

  • By Editor's Desk
  • 18 July 2024
gene editing tool

The protein dystrophin, absent in people with muscular dystrophy, will subsequently begin to be produced by the additional genetic code.

Tagged Gene Therapy, Muscular Dystrophy
Machine Learning News

New subtypes of Parkinson’s Disease can be defined by Machine Learning

  • By Editor's Desk
  • 17 July 2024
anti amyloid clinical trial alzheimer's drug

The different patterns of illness development that the subtypes exhibited allowed the investigators to identify them.

Tagged Machine Learning, Parkinson's disease
Genomics News

First identified in humans, CoRSIVs are now found in cattle

  • By Journal Updates
  • 17 July 2024
DNA Structure

CoRSIVs are sections of the genome that include chemical markers on their DNA. These markers may tell farmers things like milk output, female fertility, and disease resistance.

Tagged Cattles, CoRSIV, DNA, DNA Methylation
Research News

Research: A new neural biomarker for OCD

  • By Editor's Desk
  • 14 July 2024
alzheimer's treatments and therapies

Two to three per cent of people worldwide suffer from OCD, a prevalent and debilitating mental illness. OCD affects over two million people in the United States.

Tagged Neural Biomarker, OCD
Disease Biology

E. faecalis biofilms are targeted by a phage-derived enzyme to reduce acute Graft-Versus-Host Disease

  • By Editor's Desk
  • 12 July 2024
phage biofilm

Recently, Japanese researchers discovered endolysin, an enzyme generated from bacteriophages that may attack Enterococcus faecalis biofilms. Their results provide promise for customized allo-HCT therapies.

Tagged Biofilms, Enzyme, Host Disease
Gene Therapy News Research

Cystic Fibrosis mutation in human lung cells corrected by Prime Editing

  • By Editor's Desk
  • 11 July 2024
cystic fibrosis in the lungs

Researchers at the University of Iowa, the Broad Institute of MIT, Harvard, and Harvard have now created a gene-editing method that effectively fixes the most prevalent mutation affecting 85% of patients

Tagged Cystic Fibrosis, Lungs

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Samsung Biologics Q2 2026 Earnings: Revenue Rises to KRW 1,321 Billion Amid Global Manufacturing Expansion
Business CDMO Healthcare & Pharmaceuticals Manufacturing News

Samsung Biologics Q2 2026 Earnings: Revenue Rises to KRW 1,321 Billion Amid Global Manufacturing Expansion

24 July 202624 July 2026
Editor's Desk
Danaher Corporation Q2 2026 Financial Results; Strategic Capital Allocation, and Market Valuation Dynamics
Business Healthcare & Pharmaceuticals News

Danaher Corporation Q2 2026 Financial Results; Strategic Capital Allocation, and Market Valuation Dynamics

23 July 202623 July 2026
BiotechReality Business Intelligence Desk
Novartis Q2 2026 Results: Kisqali, Kesimpta, and Pluvicto Drive Return to Sales Growth
Business Healthcare & Pharmaceuticals News

Novartis Q2 2026 Results: Kisqali, Kesimpta, and Pluvicto Drive Return to Sales Growth

22 July 202622 July 2026
BiotechReality Business Intelligence Desk
Novo Nordisk Eli Lilly Lawsuit: Novo Nordisk Sues Eli Lilly Over Misleading Wegovy, Ozempic Ad Comparisons
Legal and Patent Affairs Healthcare & Pharmaceuticals News

Novo Nordisk Eli Lilly Lawsuit: Novo Nordisk Sues Eli Lilly Over Misleading Wegovy, Ozempic Ad Comparisons

21 July 202622 July 2026
Legal and IP Desk
Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN
Regulatory Approval Healthcare & Pharmaceuticals News

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN

18 July 202617 July 2026
Regulatory Intelligence Desk
LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C
Regulatory Approval Healthcare & Pharmaceuticals News

LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C

17 July 202617 July 2026
Regulatory Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Global Campaign Specialist – Pall Corporation
    23 July 2026
  • Key Account Manager Bioprocess – Cytiva
    20 July 2026
  • Quality Specialist – Thermo Fisher Scientific
    17 July 2026
  • HSE Specialist – Novartis
    17 July 2026
  • Field Application Specialist – Sartorius
    14 July 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter